Tg Therapeutics Stock In The News

TGTX Stock  USD 40.84  3.78  10.20%   
Our overall analysis of TG Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards TG Therapeutics. The specific impact of TG Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of TG Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using TG Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out TG Therapeutics Backtesting and TG Therapeutics Hype Analysis.
For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.

TG Therapeutics Today Top News and Investor Outlook

Yahoo News
Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025?
https://finance.yahoo.com/news/tg-therapeutics-inc-tgtx-best-143622887.html
 Bullish
Yahoo News
Biotech Stock TG Therapeutics Hits A High In Market Meltdown
https://finance.yahoo.com/m/34db3720-687f-3ca4-8833-05fbfca323b5/biotech-stock-tg-therapeutics.html
 Neutral
Yahoo News
TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround
https://finance.yahoo.com/news/tg-therapeutics-nasdaqcm-tgtx-surges-005346539.html
 Bullish
Yahoo News
S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout
https://finance.yahoo.com/m/bd865b6f-a95e-364e-a05d-892db32db098/s%26p-500-pair%2C-warren-buffet.html
 Neutral
Macroaxis News: globenewswire.com
TG Therapeutics Announces Schedule of Da...
https://www.globenewswire.com/news-release/2025/03/07/3038884/8790/en/TG-Therapeutics-Announces-Schedule-of-Data-Presentations-for-BRIUMVI-ublituximab-in-Multiple-Sclerosis-at-the-American-Academy-of-Neurology-2025-Annual-Meeting.html
 Neutral
Yahoo News
TG Therapeutics Announces Schedule of Da...
https://finance.yahoo.com/news/tg-therapeutics-announces-schedule-data-123000869.html
 Neutral
Yahoo News
This Biotech Stock Hits Buy Point After Earnings Burst
https://finance.yahoo.com/m/c6f34293-0767-384b-ba8c-47c86aa00958/this-biotech-stock-hits-buy.html
 Neutral
Yahoo News
Exploring 3 High Growth Tech Stocks In The US Market
https://finance.yahoo.com/news/exploring-3-high-growth-tech-110818308.html
 Bullish
Yahoo News
Why TG Therapeutics, Inc. (TGTX) Surged On Monday?
https://finance.yahoo.com/news/why-tg-therapeutics-inc-tgtx-100926348.html
 Neutral
Yahoo News
Company News for Mar 4, 2025
https://finance.yahoo.com/news/company-news-mar-4-2025-082000038.html
 Bullish

TG Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide TGTX and other traded companies coverage with news coverage. We help investors stay connected with TGTX headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on TGTX Stock performance. Please note that trading solely based on the TG Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
TG Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help TG Therapeutics investors visualize upcoming and past events in order to time the market based on TG Therapeutics noise-free hype analysis.
TG Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the TGTX earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about TG Therapeutics that are available to investors today. That information is available publicly through TGTX media outlets and privately through word of mouth or via TGTX internal channels. However, regardless of the origin, that massive amount of TGTX data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TG Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TG Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TG Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TG Therapeutics alpha.

TGTX Largest EPS Surprises

Earnings surprises can significantly impact TG Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-04
2024-09-300.030.02-0.0133 
2014-03-05
2013-12-31-0.17-0.19-0.0211 
2013-05-14
2013-03-31-0.15-0.17-0.0213 
2024-05-01
2024-03-31-0.04-0.07-0.0375 
2012-11-08
2012-09-30-0.12-0.16-0.0433 
2017-11-08
2017-09-30-0.43-0.48-0.0511 
View All Earnings Estimates

TG Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to TG Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
news
13th of March 2025
TG Therapeutics Sets New 12-Month High Whats Next
at thelincolnianonline.com 
Investors Business Daily at Macroaxis
11th of March 2025
Biotech Stock TG Therapeutics Hits A High In Market Meltdown
at investors.com 
Gurufocus Stories at Macroaxis
7th of March 2025
TGTX Surges on Strong Q4 Results and Briumvi Success
at gurufocus.com 
insidermonkey News
4th of March 2025
TG Therapeutics, Inc. Q4 2024 Earnings Call Transcript
at insidermonkey.com 
Yahoo News
3rd of March 2025
TG Therapeutics Soars Nearly 18 percent as Strong Q4 Results Fuel Growth Optimism
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
18th of February 2025
TG Therapeutics Announces Schedule of Data Presentations for BRI
at gurufocus.com 
Yahoo News
15th of January 2025
Is TG Therapeutics Inc. Among Tuesdays Top Gainers
at finance.yahoo.com 
Google News at Macroaxis
17th of December 2024
High Growth Tech Stocks To Watch In The United States - Yahoo Finance
at news.google.com 

TG Therapeutics Investors Sentiment

The influence of TG Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in TGTX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to TG Therapeutics' public news can be used to forecast risks associated with an investment in TGTX. The trend in average sentiment can be used to explain how an investor holding TGTX can time the market purely based on public headlines and social activities around TG Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TG Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TG Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average TG Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on TG Therapeutics.

TG Therapeutics Implied Volatility

    
  0.83  
TG Therapeutics' implied volatility exposes the market's sentiment of TG Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if TG Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that TG Therapeutics stock will not fluctuate a lot when TG Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TG Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TG Therapeutics' short interest history, or implied volatility extrapolated from TG Therapeutics options trading.

Additional Tools for TGTX Stock Analysis

When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.